NCT02502708 2020-06-04Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain TumorsLumos PharmaPhase 1 Completed81 enrolled
NCT01454596 2019-08-21CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIIINational Institutes of Health Clinical Center (CC)Phase 1/2 Completed18 enrolled 25 charts
NCT00047281 2017-07-11Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant GliomaDana-Farber Cancer InstitutePhase 2 Completed
NCT00014573 2013-04-08Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain CancerBarbara Ann Karmanos Cancer InstitutePhase 2 Completed
NCT00008008 2013-02-04Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant GliomaNational Cancer Institute (NCI)Phase 2 Completed40 enrolled